Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue.
The post Pfizer Reaches Deal on Most-Favored Nation Drug Pricing; Other Pharmas Expected to Follow appeared first on MedCity News.
